Charles & Colvard (CTHR)
(Delayed Data from NSDQ)
$0.32 USD
-0.04 (-10.17%)
Updated Apr 26, 2024 03:59 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Charles & Colvard Ltd falls in the month of June .
All items in Millions except EPS data.
6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 | |
---|---|---|---|---|---|
Sales | 30 | 43 | 39 | 29 | 32 |
Cost Of Goods | 25 | 23 | 21 | 21 | 17 |
Gross Profit | 5 | 20 | 18 | 8 | 15 |
Selling & Adminstrative & Depr. & Amort Expenses | 19 | 17 | 13 | 14 | 13 |
Income After Depreciation & Amortization | -14 | 3 | 6 | -6 | 2 |
Non-Operating Income | 0 | 0 | 1 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -14 | 3 | 6 | -6 | 2 |
Income Taxes | 6 | 1 | -6 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -20 | 2 | 13 | -6 | 2 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -20 | 2 | 13 | -6 | 2 |
Depreciation Footnote | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -13 | 3 | 6 | -6 | 3 |
Depreciation & Amortization (Cash Flow) | 1 | 0 | 1 | 0 | 0 |
Income After Depreciation & Amortization | -14 | 3 | 6 | -6 | 2 |
Earnings Per Share Data | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 |
---|---|---|---|---|---|
Average Shares | 30.38 | 31.32 | 30.23 | 28.64 | 22.11 |
Diluted EPS Before Non-Recurring Items | -0.64 | 0.08 | 0.42 | -0.03 | 0.10 |
Diluted Net EPS (GAAP) | -0.64 | 0.08 | 0.42 | -0.22 | 0.10 |
Fiscal Year end for Charles & Colvard Ltd falls in the month of June .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 7.91 | 4.95 | 5.56 | 6.64 |
Cost Of Goods | NA | 5.05 | 3.01 | 10.56 | 4.49 |
Gross Profit | NA | 2.86 | 1.94 | -5.00 | 2.15 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 5.79 | 4.58 | 4.34 | 4.32 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -2.93 | -2.64 | -9.34 | -2.17 |
Non-Operating Income | NA | 0.08 | 0.09 | 0.13 | 0.07 |
Interest Expense | NA | 0.01 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -2.87 | -2.54 | -9.21 | -2.10 |
Income Taxes | NA | 0.00 | 0.00 | 0.04 | 6.29 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -2.87 | -2.54 | -9.25 | -8.40 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -2.87 | -2.54 | -9.25 | -8.40 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 30.35 | 30.45 | 30.35 | 30.35 |
Diluted EPS Before Non-Recurring Items | NA | -0.09 | -0.08 | -0.30 | -0.28 |
Diluted Net EPS (GAAP) | NA | -0.09 | -0.08 | -0.30 | -0.28 |